Get started
Work

Supplementary Table 3 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 3: Patient Characteristics
DOI: 10.1158/2767-9764.23816143.v1
Authors: H. Catherine Wilbur, Jennifer N Durham, Su Jin Lim, Katrina Purtell, Katherine M. Bever, Daniel A. Laheru, Ana De Jesus-Acosta, Nilofer S. Azad, Bradley Wilt, Luis A. Diaz, Dung T. Le, Hao Wang
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4385455585
Cites:
Cited by:
Related to: 10